Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery
NCT ID: NCT07130422
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2023-07-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia
NCT02303704
Changes of Functional Status, Symptoms Distress and Quality of Life in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
NCT01127802
Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery
NCT07003750
Enhancing Care Study in Patients After CABG
NCT06488352
Risk Factors for Deep Sternal Wound Infection After Coronary Artery Bypass Grafting
NCT07043296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CABG surgery
CABG surgery
CABG surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CABG surgery
CABG surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing isolated coronary artery bypass graft (CABG) surgery
* Elective surgical cases
Exclusion Criteria
* Known allergy to penicillin or cephalosporins
* Refusal to provide informed consent
* Loss to follow-up within 30 days after surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maharajgunj Medical Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prajjwol Luitel
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tribhuvan University Teaching Hospital, Kathmandu, Nepal
Kathmandu, , Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
588(6-11)E2.079/080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.